CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

Launched by CHINA-JAPAN FRIENDSHIP HOSPITAL · Dec 24, 2019

Keywords

ClinConnect Summary

The CHIPs-VTE Study is looking at ways to prevent a serious condition called venous thromboembolism (VTE), which includes issues like deep vein thrombosis and pulmonary embolism, that can develop during a hospital stay. Although there are effective methods to prevent VTE, many patients in China are not receiving these treatments. This study aims to see if a new approach, which includes various quality improvement strategies, can help increase the number of patients getting the right preventive care and reduce the number of VTE cases within 90 days of being admitted to the hospital.

To participate, you need to be at least 14 years old and expect to stay in the hospital for more than three days. The study will compare two groups: one will receive these new preventive strategies while hospitalized, and the other will continue with standard care. If you join the study, you’ll be monitored for up to three months after your hospital stay to see how well the methods work. The goal is to find practical solutions that can improve care for patients in hospitals across China.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Aged ≥14 years
• • 2. Have an expected hospital stay ≥72 hours for medical and/or surgical treatment
• • 3. Written informed consent
• Exclusion Criteria:
• • 1. Inability to be followed-up at until 3 months after randomization
• • 2. Have participated in similar trials or are undergoing other clinical trials
• • 3. Refuse or are unable to give informed consent
• • 4. VTE identified on CTPA or lower extremity vein ultrasound at or any time before enrollment
• • 5. Requiring a full dose of anticoagulant treatment (e.g., recent VTE, atrial fibrillation).